GSTP1 and central nervous system cancer: A meta-analysis of 11 case-control studies with 2,404 glioma cases and 6,379 control subjects found that the risk of glioma significantly increased between the GSTP1 A114V genotype and other histopathological gliomas, not including glioblastoma multiforme (27).